Aggressive Quarantine Measures Reduce the High Morbidity of COVID-19 in Patients on Maintenance Hemodialysis and Medical Staff of Hemodialysis Facilities in Wuhan, China
- PMID: 32903303
- PMCID: PMC7316663
- DOI: 10.1159/000508579
Aggressive Quarantine Measures Reduce the High Morbidity of COVID-19 in Patients on Maintenance Hemodialysis and Medical Staff of Hemodialysis Facilities in Wuhan, China
Abstract
Introduction: Maintenance hemodialysis (MHD) patients are highly vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Medical staff of dialysis facilities without sufficient biosecurity protection are susceptible once exposed to asymptomatic coronavirus disease 2019 (COVID-19) patients. This study evaluated the epidemiological characteristics of COVID-19 in all MHD patients and medical staff of dialysis facilities in Wuhan, China.
Methods: We collected COVID-19 morbidity and mortality data from MHD patients and medical staff from 52 hemodialysis centers in Wuhan. Then, we analyzed the symptoms and signs of patients and staff in our hospital (Tongji Hospital in Wuhan), and chest CT, SARS-CoV-2 nucleic acid detection and laboratory tests were performed. After aggressive quarantine of the COVID-19 patients, we followed up on the prognosis of them.
Results: We analyzed the hemodialysis data from Wuhan and found that 10% of MHD patients and 6.0% of medical staff were suspected of COVID-19. Further detection of SARS-CoV-2 nucleic acid showed that 1.7% of MHD patients and 2.9% of medical staff were confirmed as having COVID-19. In our facility, 18.9% (46/244) of patients and 9.5% (6/63) of medical staff were suspected of COVID-19. Among them, 2.9% (7/244) of MHD patients and 4.8% (3/63) of medical staff tested positive for SARS-CoV-2 were confirmed as having COVID-19. Interestingly, 87.0% of MHD patients suspected of COVID-19 did not have obvious symptoms, but the CT screening showed features of viral pneumonia. There were no significant differences in symptoms, CT findings, comorbidity and laboratory findings of SARS-CoV-2 nucleic-acid-positive and -negative patients. We followed up these patients and found that 57 patients with COVID-19 died (COVID-19 mortality 8.9%). Two patients from our dialysis center with COVID-19 (mortality 4.3%) died. No new infections occurred in our dialysis center after aggressive quarantine was initiated.
Conclusions: The SARS-CoV-2 infection rates in MHD patients and medical staff in dialysis facilities were both high in Wuhan. Frequent chest CT and SARS-CoV-2 nucleic acid detection were needed to screen COVID-19 patients in dialysis facilities. Through the lessons of this experience on the aggressive diagnosis and quarantine measures of COVID-19 patients, we hope medical staff avoid more infections in serious epidemic areas.
Keywords: COVID-19; Infection; Maintenance hemodialysis; Quarantine; SARS-CoV-2.
Copyright © 2020 by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures


Similar articles
-
Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.Am J Kidney Dis. 2020 Oct;76(4):490-499.e1. doi: 10.1053/j.ajkd.2020.06.008. Epub 2020 Jul 3. Am J Kidney Dis. 2020. PMID: 32628990 Free PMC article.
-
Infection status and clinical characteristics of COVID-19 in maintenance hemodialysis patients in Wuhan during the omicron pandemic.Medicine (Baltimore). 2023 Sep 8;102(36):e35063. doi: 10.1097/MD.0000000000035063. Medicine (Baltimore). 2023. PMID: 37682194 Free PMC article.
-
Clinical characteristics and outcomes of maintenance hemodialysis patients with COVID-19 during the Omicron wave of the pandemic in Beijing: a single center retrospective study.BMC Nephrol. 2024 Apr 22;25(1):143. doi: 10.1186/s12882-024-03575-1. BMC Nephrol. 2024. PMID: 38649863 Free PMC article.
-
Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.Arch Gynecol Obstet. 2020 Sep;302(3):545-551. doi: 10.1007/s00404-020-05573-8. Epub 2020 Jul 21. Arch Gynecol Obstet. 2020. PMID: 32696241 Free PMC article. Review.
-
Mortality and risk factors for COVID-19 in hemodialysis patients: A systematic review and meta-analysis.Sci Prog. 2022 Jul-Sep;105(3):368504221110858. doi: 10.1177/00368504221110858. Sci Prog. 2022. PMID: 35775141 Free PMC article.
Cited by
-
A Unified Citywide Dashboard for Allocation and Scheduling Dialysis for COVID-19 Patients on Maintenance Hemodialysis.Indian J Nephrol. 2022 May-Jun;32(3):197-205. doi: 10.4103/ijn.IJN_48_21. Epub 2022 Jan 5. Indian J Nephrol. 2022. PMID: 35814318 Free PMC article.
-
Evaluation of hemodialysis patients and hemodialysis health workers with COVID-19 IgM and IgG antibody test; a multicenter study from Eskisehir, Turkiye.North Clin Istanb. 2022 Oct 27;9(5):476-783. doi: 10.14744/nci.2021.62447. eCollection 2022. North Clin Istanb. 2022. PMID: 36447586 Free PMC article.
-
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.Proc Natl Acad Sci U S A. 2021 Aug 24;118(34):e2109229118. doi: 10.1073/pnas.2109229118. Proc Natl Acad Sci U S A. 2021. PMID: 34376550 Free PMC article.
-
Current status of COVID-19 among hemodialysis patients in the East Azerbaijan Province of Iran.Hemodial Int. 2021 Apr;25(2):214-219. doi: 10.1111/hdi.12907. Epub 2020 Dec 4. Hemodial Int. 2021. PMID: 33275317 Free PMC article.
-
Incidence and Clinical Impacts of COVID-19 Infection in Patients with Hemodialysis: Systematic Review and Meta-Analysis of 396,062 Hemodialysis Patients.Healthcare (Basel). 2021 Jan 5;9(1):47. doi: 10.3390/healthcare9010047. Healthcare (Basel). 2021. PMID: 33466527 Free PMC article.
References
-
- China NHCo The new coronavirus pneumonia prevention and control program. 5th ed. [cited 2020 Feb 4]. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d44....
-
- China NHCo Guidelines for diagnosis and treatment of COVID-19. [cited 2020 Mar 3]. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb19....
-
- Zhang L, Zuo L. Current burden of end-stage kidney disease and its future trend in China. Clinical nephrology. 2016;Supplement 1;86((2016)(13)):27–28. - PubMed
-
- WHO Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. 2020 Jan;17 Available from: https://www.who.int/publications-detail/laboratory-testing-for-2019-nove....
LinkOut - more resources
Full Text Sources
Miscellaneous